Convalescent plasma: A possible treatment of COVID-19 in India.
作者信息
Teixeira da Silva Jaime A
机构信息
Independent Researcher, P. O. Box 7, Miki-cho Post Office, Ikenobe 3011-2, Kagawa-ken, 761-0799, Japan.
出版信息
Med J Armed Forces India. 2020 Apr;76(2):236-237. doi: 10.1016/j.mjafi.2020.04.006. Epub 2020 Apr 15.
Abstract
摘要
相似文献
1
Convalescent plasma: A possible treatment of COVID-19 in India.康复血浆：印度治疗新冠肺炎的一种可能方法。
Med J Armed Forces India. 2020 Apr;76(2):236-237. doi: 10.1016/j.mjafi.2020.04.006. Epub 2020 Apr 15.
2
A 63-Year-Old Woman with SARS-CoV-2 Infection, Who Developed Severe COVID-19 Pneumonia and Was Supported with Convalescent Plasma Therapy.一名63岁感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的女性，她发展为重症冠状病毒病2019（COVID-19）肺炎并接受了恢复期血浆治疗。
Am J Case Rep. 2020 Sep 29;21:e927662. doi: 10.12659/AJCR.927662.
3
Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design.恢复期血浆治疗 2019 冠状病毒病（COVID-19）：临床试验设计的考虑因素。
Transfusion. 2020 Jun;60(6):1123-1127. doi: 10.1111/trf.15843. Epub 2020 May 12.
4
Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia.恢复期血浆疗法联合瑞德西韦成功挽救了一名患有重症COVID-19肺炎的早期肝移植受者。
Ann Hepatobiliary Pancreat Surg. 2020 Nov 30;24(4):526-532. doi: 10.14701/ahbps.2020.24.4.526.
5
Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy.康复期血浆联合药物治疗重症新型冠状病毒肺炎患者：基于新制定的新型冠状病毒肺炎治疗指南的药物分析与药学监护
Front Pharmacol. 2020 Jun 24;11:966. doi: 10.3389/fphar.2020.00966. eCollection 2020.
6
[Effect of convalescent plasma and immunoglobulin on patients with severe acute respiratory syndrome: a systematic review].[康复期血浆及免疫球蛋白对重症急性呼吸综合征患者的影响：一项系统评价]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):435-438. doi: 10.3760/cma.j.cn121430-20200326-00240.
7
Clinical features of COVID-19 convalescent patients with re-positive nucleic acid detection.COVID-19 恢复期患者核酸检测复阳的临床特征。
J Clin Lab Anal. 2020 Jul;34(7):e23392. doi: 10.1002/jcla.23392. Epub 2020 Jun 7.
8
Unusual Cardiac Presentation of COVID-19 and Use of Convalescent Plasma.新冠病毒肺炎的不典型心脏表现及恢复期血浆的应用
Case Rep Cardiol. 2020 Oct 2;2020:8863195. doi: 10.1155/2020/8863195. eCollection 2020.
9
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial).印度成人中度新冠肺炎治疗中康复期血浆的应用：开放标签II期多中心随机对照试验（PLACID试验）
BMJ. 2020 Nov 3;371:m4232. doi: 10.1136/bmj.m4232.
10
Convalescent plasma therapy in the treatment of COVID-19: Practical considerations: Correspondence.恢复期血浆疗法治疗COVID-19：实际考量：通信
Int J Surg. 2020 Jul;79:204-205. doi: 10.1016/j.ijsu.2020.05.079. Epub 2020 Jun 2.
引用本文的文献
1
In silico guided screening of active components of as 3-chymotrypsin-like protease inhibitors of novel coronavirus.基于计算机模拟的新型冠状病毒3-糜蛋白酶样蛋白酶抑制剂活性成分筛选
3 Biotech. 2023 Oct;13(10):324. doi: 10.1007/s13205-023-03745-2. Epub 2023 Aug 31.
2
Clinical nursing care protocol for convalescent plasma transfusion in patients with COVID-19.新型冠状病毒肺炎患者恢复期血浆输注的临床护理方案
Int J Afr Nurs Sci. 2023;18:100518. doi: 10.1016/j.ijans.2022.100518. Epub 2022 Dec 13.
3
Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of COVID-19 Pandemic: A Narrative Review.2019年冠状病毒病大流行的流行病学、病理学、病毒学、免疫学、传播、预防、预后、诊断和治疗方面：一篇叙述性综述
Int J Prev Med. 2021 May 15;12:38. doi: 10.4103/ijpvm.IJPVM_469_20. eCollection 2021.
4
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.恢复期血浆用于 COVID-19 的预防和治疗：系统评价和定量分析。
JMIR Public Health Surveill. 2021 Apr 7;7(4):e25500. doi: 10.2196/25500.
5
Review of investigational drugs for coronavirus disease 2019.2019年冠状病毒病研究性药物综述
J Educ Health Promot. 2021 Jan 28;10:31. doi: 10.4103/jehp.jehp_457_20. eCollection 2021.
6
Immunotherapies and immunomodulatory approaches in clinical trials - a mini review.免疫疗法和临床试验中的免疫调节方法——小型综述。
Hum Vaccin Immunother. 2021 Jul 3;17(7):1897-1909. doi: 10.1080/21645515.2020.1871295. Epub 2021 Feb 12.
7
A 21st Century Evil: Immunopathology and New Therapies of COVID-19.二十一世纪的罪恶：COVID-19 的免疫病理学和新疗法。
Front Immunol. 2020 Oct 27;11:562264. doi: 10.3389/fimmu.2020.562264. eCollection 2020.
8
COVID-19 in Kidney Transplantation: Epidemiology, Management Considerations, and the Impact on Kidney Transplant Practice.肾移植中的新型冠状病毒肺炎：流行病学、管理考量及对肾移植实践的影响
Transplant Direct. 2020 Jul 15;6(8):e582. doi: 10.1097/TXD.0000000000001031. eCollection 2020 Aug.
9
Convalescent plasma appears efficacious and safe in COVID-19.康复期血浆疗法在治疗新冠肺炎方面似乎有效且安全。
Ther Adv Infect Dis. 2020 Sep 28;7:2049936120957931. doi: 10.1177/2049936120957931. eCollection 2020 Jan-Dec.
10
Perspective on the Role of Antibodies and Potential Therapeutic Drugs to Combat COVID-19.对抗 COVID-19 中抗体和潜在治疗性药物作用的思考。
Protein J. 2020 Dec;39(6):631-643. doi: 10.1007/s10930-020-09921-0. Epub 2020 Oct 9.
本文引用的文献
1
Healthcare impact of COVID-19 epidemic in India: A stochastic mathematical model.印度新冠疫情的医疗保健影响：一个随机数学模型。
Med J Armed Forces India. 2020 Apr;76(2):147-155. doi: 10.1016/j.mjafi.2020.03.022. Epub 2020 Apr 2.
2
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.新型冠状病毒病治疗药物的研究进展。
Pharmacotherapy. 2020 May;40(5):416-437. doi: 10.1002/phar.2398. Epub 2020 May 6.
3
Deployment of convalescent plasma for the prevention and treatment of COVID-19.恢复期血浆在 COVID-19 预防和治疗中的应用。
J Clin Invest. 2020 Jun 1;130(6):2757-2765. doi: 10.1172/JCI138745.
4
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.5 例危重症 COVID-19 患者接受恢复期血浆治疗。
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
5
Covid-19: FDA approves use of convalescent plasma to treat critically ill patients.新冠疫情：美国食品药品监督管理局批准使用康复期血浆治疗重症患者。
BMJ. 2020 Mar 26;368:m1256. doi: 10.1136/bmj.m1256.
6
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.Fc 介导的呼吸道合胞病毒感染和疾病中的抗体效应功能。
Front Immunol. 2019 Mar 22;10:548. doi: 10.3389/fimmu.2019.00548. eCollection 2019.
Zotero 插件